Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Investigating biofilm formation on temporary dental implant components

Official title: Temporary push-on Rings of Antimicrobial Alloys for Transmucosal Implant Abutment Systems: a Randomized Clinical Study on Early and Mature Biofilm Formation

Run by University Hospital, Basel, Switzerland · NCT05122897 · Data updated 2026-11-12

This study is testing if a new type of dental implant material can reduce harmful bacteria buildup compared to the standard material to help prevent gum diseases.

More Peri-implantitis trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment33 (estimated)
SponsorUniversity Hospital, Basel, Switzerland
Academic / other
Locations1 site (Basel)
StatusRecruiting
StartedJanuary 11, 2022
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedAugust 11, 2026
Trial IDNCT05122897 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals with one or more bone-level titanium implants who are not experiencing systemic illness or active periodontitis.

Probably not a fit

Patients with systemic illnesses, heavy smokers, or those with active periodontitis may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study examines the formation and composition of oral biofilm on temporary push-on cones made from a noble-alloy material compared to a titanium alloy used in dental implants. It evaluates biofilm development at three time points: early (48 hours), mature (2 weeks), and long-term (3 months). The goal is to determine if the new material can reduce bacterial colonization and the risk of peri-implant diseases compared to the current standard. Participants will be monitored for biofilm accumulation and related outcomes.

Why it matters

Potential benefit: If successful, this study could lead to improved dental implant materials that reduce the risk of peri-implantitis and enhance oral health.

How similar studies have gone: Other studies have shown promising results with similar approaches in reducing biofilm accumulation on dental materials, suggesting potential for success in this investigation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Informed Consent signed by the subject
* Presence of one or more bone level titanium implant prior to insertion of the final restoration
* No systemic illness
* No heavy smoking (smoking \<10 cigarettes/day)
* No pregnancy
* No active periodontitis (probing pocket depth ≤4 mm)
* No pharmacological treatment or antibiotic therapy during or up to three months before the study

Exclusion Criteria:

* Systemic illness (e.g. Diabetes)
* Heavy smoking (smoking \>10 cigarettes/day)
* Known or suspected non-compliance, drug or alcohol abuse
* Pregnancy
* Active periodontitis (probing pocket depth \>4 mm)
* Pharmacological treatment or antibiotic therapy during or up to three months before the study

Where it's running

  • UZB (University Center for Dental Medicine Basel)
    Basel, Switzerland
    Recruiting

Study contacts

  • Principal investigator: Nicola U. Zitzmann, Prof. Dr. — University Center for Dental Medicine Basel
  • Study coordinator: Nicola U. Zitzmann, Prof. Dr.
  • Email: n.zitzmann@unibas.ch
  • Phone: +41 61 267 26 36

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.